Type 1 Diabetes Mellitus research hub
5 indexed studies · 2 currently recruiting
- active not recruitingPHASE3
The Fenofibrate And Microvascular Events in Type 1 Diabetes Eye.
This study looks into whether a daily tablet called fenofibrate can help protect the eyes of adults with Type 1 diabetes. It aims to see if this medicine can prevent or slow down eye damage, which is a common problem for people with diabetes.
Australia · Hong Kong · New Zealand - active not recruitingPHASE2
A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic Retinopathy
This study is testing a new medicine, BI 764524, for people with an eye condition called diabetic retinopathy. It aims to see if it improves their vision and how often it should be given.
United States · Germany · Hungary - ongoing, recruitingHuman Pharmacology (Phase I)- Other
A phase 1, open-label trial in healthy subjects and in subjects with diabetes investigating pharmacokinetics, tolerability, safety, and food effect following single and multiple dosing of danegaptide
This study is testing a new medicine called danegaptide. It looks at how the body handles the medicine, if it's safe, and whether food affects it. This is for people with diabetes and healthy volunteers to help understand how this medicine might one day treat diabetic retinopathy.
Sweden - recruitingNA
Is Community Based Monitoring of Diabetic Maculopathy and Pre-proliferative Diabetic Retinopathy Safe?
This study looks at whether opticians in your local area can help check for eye problems caused by diabetes, using special scans. It aims to make it easier to get checked and reduce hospital visits, while making sure it's safe and effective.
United Kingdom - recruitingNA
Early Percutaneous Transluminal Angioplasty in Diabetic Foot Syndrome (PTA-DFS)
This study looks at treating diabetic foot ulcers with a procedure called angioplasty. Researchers want to know if having this treatment quickly makes a bigger difference to healing than having it later. It's about finding the best timing for care.
Germany